Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Net Sales
398.25
214.52
Other Operating Income
0.00
0.00
Total Operating income
398.25
214.52
Raw Material Cost
91.64
31.96
Purchase of Finished goods
89.83
70.30
(Increase) / Decrease In Stocks
-0.76
3.88
Employee Cost
60.37
35.46
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
67.47
31.32
Total Expenditure (Excl Depreciation)
308.55
172.92
Operating Profit (PBDIT) excl Other Income
89.70
41.60
Other Income
19.26
2.82
Operating Profit (PBDIT)
108.96
44.42
Interest
21.55
9.45
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
87.41
34.97
Depreciation
16.84
10.02
Profit Before Tax
70.57
24.95
Tax
12.23
-7.76
Provisions and contingencies
0.00
0.00
Profit After Tax
58.34
32.71
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
58.34
32.71
Share in Profit of Associates
0.00
0.00
Minority Interest
0.22
-1.26
Other related items
0.00
0.00
Consolidated Net Profit
58.56
31.45
Equity Capital
46.05
30.51
Face Value
10.0
10.0
Reserves
740.13
173.76
Earnings per share (EPS)
12.72
10.31
Diluted Earnings per share
16.12
12.21
Operating Profit Margin (Excl OI)
23.73%
19.39%
Gross Profit Margin
23.13%
16.3%
PAT Margin
15.43%
15.25%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 13.32% vs 174.72% in Mar 2024
Standalone Net Profit
YoY Growth in year ended Mar 2025 is 355.56% vs -32.50% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -10,300.00% vs 96.07% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 140.59% vs 26.64% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of Senores Pharma. With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
398.25
0
398.25
Other Operating Income
0.00
0.00
0.00
Total Operating income
398.25
0
398.25
Raw Material Cost
91.64
0
91.64
Purchase of Finished goods
89.83
0
89.83
(Increase) / Decrease In Stocks
-0.76
0
-0.76
Employee Cost
60.37
0
60.37
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
67.47
0.00
67.47
Total Expenditure (Excl Depreciation)
308.55
0
308.55
Operating Profit (PBDIT) excl Other Income
89.70
0.00
89.70
Other Income
19.26
0
19.26
Operating Profit (PBDIT)
108.96
0
108.96
Interest
21.55
0
21.55
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
87.41
0
87.41
Depreciation
16.84
0
16.84
Profit Before Tax
70.57
0
70.57
Tax
12.23
0
12.23
Provisions and contingencies
0.00
0
0.00
Profit After Tax
58.34
0
58.34
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
58.34
0
58.34
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.22
0
0.22
Other related items
0.00
0.00
0.00
Consolidated Net Profit
58.56
0
58.56
Equity Capital
46.05
0
46.05
Face Value
10.00
0
0.00
Reserves
740.13
0
740.13
Earnings per share (EPS)
12.72
0
12.72
Diluted Earnings per share
16.12
0
16.12
Operating Profit Margin (Excl OI)
23.73%
0%
0.00
23.73%
Gross Profit Margin
23.13%
0%
0.00
23.13%
PAT Margin
15.43%
0%
0.00
15.43%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 38.54 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 13.32% vs 174.72% in Mar 2024
Annual - Standalone Net Profit
Standalone Net Profit 3.69 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 355.56% vs -32.50% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -7.28 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -10,300.00% vs 96.07% in Mar 2024
Annual - Interest
Interest 6.52 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 140.59% vs 26.64% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -18.89%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
